Forian (FORA)
NASDAQ:FORA
FORA Stock Chart & Stats
$2.08
$0.02(0.99%)
At close: 4:00 PM EST
$2.08
$0.02(0.99%)
Day’s Range― - ―
52-Week Range$1.64 - $2.71
Previous CloseN/A
Volume6.00
Average Volume (3M)272.50K
Market Cap
$66.79M
Enterprise Value$53.90M
Total Cash (Recent Filing)$31.55M
Total Debt (Recent Filing)$12.14K
Price to Earnings (P/E)―
Beta0.55
Next Earnings
May 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding31,208,752
10 Day Avg. Volume42,136
30 Day Avg. Volume272,505
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)2.21
Price to Sales (P/S)2.18
P/FCF Ratio22.85
Enterprise Value/Market Cap0.81
Enterprise Value/Revenue1.78
Enterprise Value/Gross Profit3.39
Enterprise Value/Ebitda-24.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.04
Revenue Forecast (FY)$32.17M
Bulls Say, Bears Say
Bulls Say
Take-private TransactionA CEO-led, board-approved take-private with committed equity gives shareholders a defined liquidity outcome and removes public-market quarterly pressure. Structurally, this reduces near-term financing uncertainty and lets management pursue multi-quarter strategic initiatives without short-term market scrutiny.
Conservative Balance SheetThe company’s minimal leverage and sizable equity position materially lower bankruptcy and refinancing risk, improving resilience to demand swings. Over a 2–6 month horizon this capital structure enables operational continuity and optionality for investment or restructuring without urgent external financing.
Improved Cash GenerationA return to positive operating and free cash flow demonstrates the business can generate internal liquidity to fund operations and reduce reliance on external capital. If sustained, this cash generation improves self-funding capacity for product development and customer expansion over the medium term.
Bears Say
Persistent UnprofitabilityContinued negative EBITDA and net losses indicate the core business has not reached consistent profitability. Over months, this limits retained earnings, constrains reinvestment capacity, and may force cost cuts or additional financing if cash generation falters, undermining durable margin improvement.
Inconsistent Cash Flow HistoryHistoric swings in cash flow create uncertainty about the repeatability of 2025’s positive results. Structural unpredictability in operating cash increases the risk that future quarters could require external funding or operational adjustments, reducing confidence in sustainable cash-funded growth.
Negative Returns On EquityNegative ROE shows the company’s equity base is not producing positive economic returns, signaling weak monetization of assets and limited shareholder value creation. Structurally, this challenges the business model’s ability to convert investments into profit over the medium term without operational improvement.
Forian News
FORA FAQ
What was Forian’s price range in the past 12 months?
Forian lowest stock price was $1.64 and its highest was $2.71 in the past 12 months.
What is Forian’s market cap?
Forian’s market cap is $66.79M.
When is Forian’s upcoming earnings report date?
Forian’s upcoming earnings report date is May 19, 2026 which is in 36 days.
How were Forian’s earnings last quarter?
Forian released its earnings results on Mar 27, 2026. The company reported -$0.059 earnings per share for the quarter, missing the consensus estimate of -$0.02 by -$0.039.
Is Forian overvalued?
According to Wall Street analysts Forian’s price is currently Overvalued.
Does Forian pay dividends?
Forian does not currently pay dividends.
What is Forian’s EPS estimate?
Forian’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Forian have?
Forian has 31,208,752 shares outstanding.
What happened to Forian’s price movement after its last earnings report?
Forian reported an EPS of -$0.059 in its last earnings report, missing expectations of -$0.02. Following the earnings report the stock price went up 0.485%.
Which hedge fund is a major shareholder of Forian?
Currently, no hedge funds are holding shares in FORA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Forian Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.46%
12-Months-Change
Fundamentals
Return on Equity
-9.43%
Trailing 12-Months
Asset Growth
-6.01%
Trailing 12-Months
Company Description
Forian
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Technical Analysis
Ownership Overview
23.11% Insiders
2.59% Mutual Funds
8.79% Other Institutional Investors
63.24% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---